Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
about
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementClosed-loop insulin delivery for treatment of type 1 diabetesOvernight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesIn silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies.The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.Multinight "bedside" closed-loop control for patients with type 1 diabetes.Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas.Switched LPV Glucose Control in Type 1 Diabetes.Modular closed-loop control of diabetesMulticenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.Novel insulin delivery profiles for mixed meals for sensor-augmented pump and closed-loop artificial pancreas therapy for type 1 diabetes mellitusOvernight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.Evaluation of stochastic adjustment for glucose sensor bias during closed-loop insulin deliveryDay and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementAlgorithms for a closed-loop artificial pancreas: the case for model predictive control.Artificial pancreas: model predictive control design from clinical experienceDiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trialsDiAs user interface: a patient-centric interface for mobile artificial pancreas systemsFeasibility study of a bio-inspired artificial pancreas in adults with type 1 diabetes.Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.A closed-loop artificial pancreas using a proportional integral derivative with double phase lead controller based on a new nonlinear model of glucose metabolismModel-based sensor-augmented pump therapyIn silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control.Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes.Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemiaArtificial pancreas: past, present, futureAP@home: a novel European approach to bring the artificial pancreas home.In silico Models of Alcohol Dependence and TreatmentClinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system.Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies.Design and in silico evaluation of an intraperitoneal-subcutaneous (IP-SC) artificial pancreas.Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.Multiple-Input Subject-Specific Modeling of Plasma Glucose Concentration for Feedforward Control.A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algoriRole of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.Evaluating the Performance of a Novel Embedded Closed-loop System.
P2860
Q26769878-067697D6-D46C-4565-8FCD-51F22EBCD72FQ27008127-53D7CC0C-7323-4E6C-8AD9-6F28F6EB8B12Q28741005-0891E2DE-BFBF-446F-9AB9-5F62CE7E9D36Q30252581-63AF84D1-1995-48EE-B4DB-0B4955DFB095Q30276534-8B73AAB4-9F0A-422F-BF42-1FD480055F28Q30300933-99692C9A-D23C-4272-875C-1A97CF17A284Q30300948-021486CC-DAA3-4711-8D56-844CCF4E94DFQ30301086-8830E652-7AB7-4D4B-8B4F-12717577AFABQ30352479-E8A1518D-D5D7-4995-9E91-2433C757A007Q30370427-F8818590-EE1D-4D0A-9058-143CF3C2F324Q30370610-E5355B4E-3D6E-477E-87A0-8AA64CB3D4F8Q30370613-D00AE80B-5579-4710-8142-08F229EBED8CQ30371148-54F715FF-CF83-4187-BB63-D92D15071551Q30371580-555618EC-2FF9-4721-A980-C6C0C06B007DQ30384405-C2183E52-97C0-462D-84A4-9EE327B0A103Q30407675-22DBF8AA-581A-4C94-9A09-FF3BCED8774EQ30409243-55FEEBA6-009C-4C0E-A5A8-A14C6A286468Q30409797-68D789B0-4703-4B39-84BA-FFF6D0DD74C0Q30409808-DD9FC9BA-1B8C-4CBB-AD73-763F724F7135Q30409819-6DF42C14-A296-43DC-87CD-3287CA8A3F76Q30409823-A2D0A82D-6882-4C68-93C6-E7240C0E556AQ30410965-596D1F2E-23D2-407C-9559-1760E39EF05DQ30412117-6EE71D74-9631-44BD-B5B5-4D579E3FB946Q30413389-C5A648AC-20DF-4105-83EB-ECE60BAD7D33Q30414570-39D37676-FC29-4FB7-8F79-AFE0BA7E0320Q30415517-E67C743D-FE79-4D62-BB91-9F3DF0383B43Q30416241-750B371E-BB63-44E1-9481-D2513B1B3B80Q30417379-C1AFFF50-18A6-4C14-A39B-259646F659CCQ30424200-125CBCFB-4DE5-49A4-B468-CF9657FC6C0CQ30424293-3C671747-D60F-42CC-8473-B92693DF7B4EQ30428337-27E8F959-4E1E-47E1-AA96-DC34F2413F18Q33642470-6FACB64A-635F-415C-9A25-D4F58DF16835Q34151693-98519CE8-0B55-4B8E-AA31-5E891A0CF5BDQ34243374-AC5BDFA8-F8B5-4F06-BADB-53D08A0FF7FDQ34245943-33BB3A40-88A5-4D67-8FE9-D320B302B392Q34360613-7E90A4C2-39DD-4A32-86EF-C416C05AF2F0Q34986246-4BB2B91E-0023-4D3C-BF6C-1163947E7D34Q35336990-1ECED9C7-71A1-45B3-B452-3A64C7B98C96Q35682682-91660EF5-A239-4C2F-B2EE-B938A4CA95BEQ35682761-B7DE393D-2841-47B2-92A3-5155551C956F
P2860
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multinational study of subcuta ...... litus: summary of the results.
@ast
Multinational study of subcuta ...... litus: summary of the results.
@en
type
label
Multinational study of subcuta ...... litus: summary of the results.
@ast
Multinational study of subcuta ...... litus: summary of the results.
@en
prefLabel
Multinational study of subcuta ...... litus: summary of the results.
@ast
Multinational study of subcuta ...... litus: summary of the results.
@en
P2093
P2860
P50
P1476
Multinational study of subcuta ...... litus: summary of the results.
@en
P2093
Alberto Maran
Angelo Avogaro
Anne Farret
Boris Kovatchev
Eric Renard
Giuseppe De Nicolao
Jerome Place
Lalo Magni
Marc Breton
Silvana Costa
P2860
P304
P356
10.1177/193229681000400611
P577
2010-11-01T00:00:00Z